SCHEMBL15619476

SCHEMBL15619476

COc1ccc(I)cc1-c1oc2ccccc2c(=O)c1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.76
TSHR P16473 4/20 0.76
ALOX15 P16050 4/20 0.76
HTT P42858 2/20 0.76
SMN1; SMN2 Q16637 2/20 0.76
CYP3A4 P08684 9/20 0.72
MEN1 O00255 8/20 0.72
KMT2A Q03164 8/20 0.72
HSD17B10 Q99714 7/20 0.72
ALDH1A1 P00352 5/20 0.72
HPGD P15428 5/20 0.72
TP53 P04637 6/20 0.66
MAPT P10636 5/20 0.66
LMNA P02545 3/20 0.66
CASP1 P29466 1/20 0.66
CASP7 P55210 1/20 0.66
TUBB4A P04350 1/20 0.62
TUBB P07437 1/20 0.62
ADORA3 P0DMS8 1/20 0.62
TUBA3C P0DPH7 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17079654 0.86 KDM4E (1.00) KDM4ETSHRALOX15HTTSMN1; SMN2
SCHEMBL15619540 0.86 KDM4E (0.77) KDM4ETSHRALOX15HTTSMN1; SMN2
SCHEMBL15619629 0.85 KDM4E (0.76) KDM4ETSHRALOX15HTTSMN1; SMN2
SCHEMBL15619432 0.85 KDM4E (0.76) KDM4ETSHRALOX15HTTSMN1; SMN2
SCHEMBL21446879 0.84 KDM4E (0.75) KDM4ETSHRALOX15HTTSMN1; SMN2
SCHEMBL31675993 0.84 KDM4E (1.00) KDM4ETSHRALOX15HTTSMN1; SMN2
SCHEMBL4649481 0.84 KDM4E (1.00) KDM4ETSHRALOX15HTTSMN1; SMN2
SCHEMBL15619433 0.81 KDM4E (0.70) KDM4ETSHRALOX15HTTSMN1; SMN2
3-Hydroxy-3',4'-Dimethoxyflavone SCHEMBL15676607 0.80 KDM4E (1.00) KDM4ETSHRALOX15HTTSMN1; SMN2
3-Hydroxy-3',4'-Dimethoxyflavone SCHEMBL30139617 0.80 KDM4E (1.00) KDM4ETSHRALOX15HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9629822-B2 Flavonoid based antiviral targets UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-04-25 US disclosed
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, (US) 2015-07-30 US disclosed
WO-2014047551-A1 FLAVONOID BASED ANTIVIRAL TARGETS UNIVERSITY OF CENTER FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150209323-A1 FLAVONOID BASED ANTIVIRAL TARGETS RBM28, MAVS, HAVCR2 KDM4E 3580/4885TSHR 3813/4885ALOX15 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.